A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (ALUMMINATE)

May 30, 2024 updated by: Celgene

A Phase 3, Randomized, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) - ALUMMINATE RRMM

The purpose of this study is to evaluate the efficacy and safety of alnuctamab compared to standard of care regimens in participants with relapsed or refractory multiple myeloma (RRMM).

Study Overview

Study Type

Interventional

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Buenos Aires
      • Florencio Varela, Buenos Aires, Argentina, 1888
        • Local Institution - 0222
      • La Plata, Buenos Aires, Argentina, 1900
        • Local Institution - 0001
      • Pilar, Buenos Aires, Argentina, 1629
        • Local Institution - 0262
    • Ciudad Autónoma De Buenos Aires
      • Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina, C1118AAT
        • Local Institution - 0002
    • New South Wales
      • Liverpool, New South Wales, Australia, 2170
        • Local Institution - 0260
      • Macquarie University, New South Wales, Australia, 2109
        • Local Institution - 0246
      • Waratah, New South Wales, Australia, 2298
        • Local Institution - 0022
    • Queensland
      • Brisbane, Queensland, Australia, 4120
        • Local Institution - 0397
    • Victoria
      • Box Hill, Victoria, Australia, 3128
        • Local Institution - 0021
      • Clayton, Victoria, Australia, 3168
        • Local Institution - 0019
      • Melbourne, Victoria, Australia, 3004
        • Local Institution - 0018
      • Melbourne, Victoria, Australia, 3065
        • Local Institution - 0003
      • Salzburg, Austria, 5020
        • Local Institution - 0334
      • Wien, Austria, 1090
        • Local Institution - 0332
    • Niederösterreich
      • St. Polten, Niederösterreich, Austria, 3100
        • Local Institution - 0333
    • Tirol
      • Innsbruck, Tirol, Austria, 6020
        • Local Institution - 0337
    • Antwerpen
      • Brasschaat, Antwerpen, Belgium, 2930
        • Local Institution - 0284
    • Liège
      • Verviers, Liège, Belgium, 4800
        • Local Institution - 0280
    • Namur
      • Yvoir, Namur, Belgium, 5530
        • Local Institution - 0279
    • Vlaams-Brabant
      • Leuven, Vlaams-Brabant, Belgium, 3000
        • Local Institution - 0286
      • Rio de Janeiro, Brazil, 22250-905
        • Local Institution - 0291
      • São Paulo, Brazil, 05652-900
        • Local Institution - 0211
    • Minas Gerais
      • Belo Horizonte, Minas Gerais, Brazil, 30110-022
        • Local Institution - 0274
    • Rio Grande Do Norte
      • Natal, Rio Grande Do Norte, Brazil, 59025050
        • Local Institution - 0351
    • São Paulo
      • Sao Paulo, São Paulo, Brazil, 01509-010
        • Local Institution - 0369
    • Alberta
      • Calgary, Alberta, Canada, T2N 4N2
        • Local Institution - 0417
      • Edmonton, Alberta, Canada, T6G1Z2
        • Local Institution - 0423
    • Ontario
      • London, Ontario, Canada, N6A 5W9
        • Local Institution - 0402
      • Toronto, Ontario, Canada, M5G 2M9
        • Local Institution - 0395
    • Quebec
      • Montreal, Quebec, Canada, H1T 2M4
        • Local Institution - 0031
      • Montréal, Quebec, Canada, H2X 1P1
        • Local Institution - 0098
    • Metropolitana DE Santiago
      • Santiago, Metropolitana DE Santiago, Chile, 7580206
        • Local Institution - 0027
    • Región Metropolitana De Santiago
      • Santiago, Región Metropolitana De Santiago, Chile, 7500921
        • Local Institution - 0030
      • Santiago, Región Metropolitana De Santiago, Chile, 7650568
        • Local Institution - 0029
      • Santiago, Región Metropolitana De Santiago, Chile, 7620002
        • Local Institution - 0026
      • Qingdao, China, 266011
        • Local Institution - 0367
    • Beijing
      • Beijing, Beijing, China
        • Local Institution - 0413
      • Beijing, Beijing, China, 100020
        • Local Institution - 0230
      • Beijing, Beijing, China, 100034
        • Local Institution - 0040
      • Changping, Beijing, China, 102200
        • Local Institution - 0366
    • Chongqing
      • Chongqing, Chongqing, China, 400016
        • Local Institution - 0057
    • Guangdong
      • Guangzhou, Guangdong, China, 510120
        • Local Institution - 0080
      • Guangzhou, Guangdong, China, 510060
        • Local Institution - 0066
      • Guangzhou, Guangdong, China, 510515
        • Local Institution - 0226
      • Shenzhen, Guangdong, China, 518036
        • Local Institution - 0368
    • Hebei
      • Baoding, Hebei, China, 071030
        • Local Institution - 0365
      • Shijiazhuang, Hebei, China, 050051
        • Local Institution - 0082
    • Henan
      • Zhengzhou, Henan, China, 450008
        • Local Institution - 0041
    • Hubei
      • Wuhan, Hubei, China, 430030
        • Local Institution - 0075
    • Hunan
      • Changsha, Hunan, China, 410011
        • Local Institution - 0062
      • Changsha, Hunan, China, 410013
        • Local Institution - 0053
    • Jiangsu
      • Nanjing, Jiangsu, China, 210000
        • Local Institution - 0055
      • Suzhou, Jiangsu, China, 215006
        • Local Institution - 0067
      • Xuzhou, Jiangsu, China, 221006
        • Local Institution - 0377
    • Liaoning
      • Shenyang, Liaoning, China, 110004
        • Local Institution - 0044
    • Shaanxi
      • Xi'An, Shaanxi, China, 710004
        • Local Institution - 0072
    • Shandong
      • Jinan, Shandong, China, 250014
        • Local Institution - 0077
      • Jinan, Shandong, China, 250117
        • Local Institution - 0083
    • Shanghai
      • Shanghai, Shanghai, China, 200032
        • Local Institution - 0273
      • Shanghai, Shanghai, China, 200081
        • Local Institution - 0421
    • Shanxi
      • Taiyuan, Shanxi, China, 030000
        • Local Institution - 0245
    • Tianjin
      • Tianjin, Tianjin, China, 300052
        • Local Institution - 0056
      • Tianjin, Tianjin, China, 300308
        • Local Institution - 0422
    • Zhejiang
      • Hangzhou, Zhejiang, China, 310003
        • Local Institution - 0070
      • Hangzhou, Zhejiang, China, 310003
        • Local Institution - 0203
      • Praha 2, Czechia, 12808
        • Local Institution - 0012
    • Brno-město
      • Brno, Brno-město, Czechia, 625 00
        • Local Institution - 0013
    • Olomoucký Kraj
      • Olomouc, Olomoucký Kraj, Czechia, 779 00
        • Local Institution - 0247
    • Haute-Garonne
      • Toulouse, Haute-Garonne, France, 31100
        • Local Institution - 0118
    • Languedoc-Roussillon
      • Montpellier, Languedoc-Roussillon, France, 34295
        • Local Institution - 0225
    • Lorraine
      • Vandoeuvre lès Nancy, Lorraine, France, 54511
        • Local Institution - 0224
    • Nord
      • Lille, Nord, France, 59000
        • Local Institution - 0084
    • Pays-de-la-Loire
      • Nantes, Pays-de-la-Loire, France, 44000
        • Local Institution - 0085
    • Rhône
      • Pierre-Bénite, Rhône, France, 69310
        • Local Institution - 0192
      • Hamburg, Germany, 22763
        • Local Institution - 0339
    • Baden-Württemberg
      • Heidelberg, Baden-Württemberg, Germany, 69120
        • Local Institution - 0331
      • Tübingen, Baden-Württemberg, Germany, 72076
        • Local Institution - 0330
    • Sachsen
      • Dresden, Sachsen, Germany, 01307
        • Local Institution - 0335
      • Leipzig, Sachsen, Germany, 04103
        • Local Institution - 0329
    • Attikí
      • Athens, Attikí, Greece, 115 28
        • Local Institution - 0004
      • Chaidari, Attikí, Greece, 12462
        • Local Institution - 0136
      • Budapest, Hungary, 1088
        • Local Institution - 0104
      • Budapest, Hungary, 1097
        • Local Institution - 0105
    • Szabolcs-Szatmár-Bereg
      • Nyiregyhaza, Szabolcs-Szatmár-Bereg, Hungary, 4400
        • Local Institution - 0103
    • Vas
      • Szombathely, Vas, Hungary, 9700
        • Local Institution - 0108
    • Andhra Pradesh
      • Visakhapatnam, Andhra Pradesh, India, 530040
        • Local Institution - 0370
    • Haryana
      • Gurugram, Haryana, India, 122011
        • Local Institution - 0362
    • Karnataka
      • Bangalore, Karnataka, India, 560092
        • Local Institution - 0403
    • Uttar Pradesh
      • Lucknow, Uttar Pradesh, India, 226014
        • Local Institution - 0399
    • West Bengal
      • Kolkata, West Bengal, India, 700094
        • Local Institution - 0398
      • Cork, Ireland, T12 E8YV
        • Local Institution - 0281
      • Dublin, Ireland, D04 N2E0
        • Local Institution - 0371
      • Dublin, Ireland, D08 E9P6
        • Local Institution - 0285
      • Limerick, Ireland, V94 F858
        • Local Institution - 0269
    • Emilia-Romagna
      • Meldola, Emilia-Romagna, Italy, 47014
        • Local Institution - 0096
    • Milano
      • Legnano, Milano, Italy, 20025
        • Local Institution - 0294
      • Milan, Milano, Italy, 20162
        • Local Institution - 0265
    • Sicilia
      • Palermo, Sicilia, Italy, 90127
        • Local Institution - 0410
      • Aomori, Japan, 030-8553
        • Local Institution - 0419
      • Chiba, Japan, 260-8677
        • Local Institution - 0383
      • Kumamoto, Japan, 860-8556
        • Local Institution - 0391
      • Kyoto, Japan, 602-8566
        • Local Institution - 0389
      • Okayama, Japan, 701-1192
        • Local Institution - 0388
      • Tokyo, Japan, 150-8935
        • Local Institution - 0384
    • Aichi
      • Anjo, Aichi, Japan, 446-8602
        • Local Institution - 0409
      • Nagoya, Aichi, Japan, 467-8602
        • Local Institution - 0387
    • Chiba
      • Kamogawa, Chiba, Japan, 296-0041
        • Local Institution - 0407
      • Kashiwa, Chiba, Japan, 277-8577
        • Local Institution - 0385
    • Kanagawa
      • Isehara, Kanagawa, Japan, 259-1193
        • Local Institution - 0386
    • Osaka
      • Osaka-sayama, Osaka, Japan, 589-8511
        • Local Institution - 0390
    • Tochigi
      • Shimotsuga, Tochigi, Japan, 321-0293
        • Local Institution - 0381
    • Tokyo
      • Koto, Tokyo, Japan, 135-8550
        • Local Institution - 0382
    • Kyǒnggi-do
      • Seongnam, Kyǒnggi-do, Korea, Republic of, 13620
        • Local Institution - 0240
    • Pusan-Kwangyǒkshi
      • Busan, Pusan-Kwangyǒkshi, Korea, Republic of, 49201
        • Local Institution - 0221
    • Seoul-teukbyeolsi [Seoul]
      • Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of, 03080
        • Local Institution - 0036
      • Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of, 05505
        • Local Institution - 0239
      • Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of, 06351
        • Local Institution - 0034
      • Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of, 06591
        • Local Institution - 0035
      • Oslo, Norway, 0450
        • Local Institution - 0193
    • Akershus
      • Løenskog, Akershus, Norway, 1474
        • Local Institution - 0137
    • Hordaland
      • Bergen, Hordaland, Norway, 5021
        • Local Institution - 0115
      • Lisboa, Portugal, 1500-650
        • Local Institution - 0255
    • Lisboa
      • Lisbon, Lisboa, Portugal, 1099-023
        • Local Institution - 0242
      • Lisbon, Lisboa, Portugal, 1649-035
        • Local Institution - 0415
      • Brasov, Romania, 500052
        • Local Institution - 0171
      • București, Romania, 050098
        • Local Institution - 0414
    • București
      • Bucuresti, București, Romania, 022328
        • Local Institution - 0169
      • Jerez de la Frontera, Spain, 11407
        • Local Institution - 0202
      • Salamanca, Spain, 37007
        • Local Institution - 0006
      • Santiago de Compostela, Spain, 15706
        • Local Institution - 0007
      • València, Spain, 46026
        • Local Institution - 0009
    • Barcelona [Barcelona]
      • Badalona, Barcelona [Barcelona], Spain, 08916
        • Local Institution - 0011
    • Murcia, Región De
      • El Palmar, Murcia, Murcia, Región De, Spain, 30120
        • Local Institution - 0234
    • Navarra
      • Pamplona, Navarra, Spain, 31008
        • Local Institution - 0008
    • Västra Götalands Län [se-14]
      • Borås, Västra Götalands Län [se-14], Sweden, 501 82
        • Local Institution - 0114
      • Gothenburg, Västra Götalands Län [se-14], Sweden, 413 45
        • Local Institution - 0111
      • Zürich, Switzerland, 8063
        • Local Institution - 0338
    • Berne
      • Bern, Berne, Switzerland, 3010
        • Local Institution - 0336
    • Sankt Gallen
      • st.Gallen, Sankt Gallen, Switzerland, 9007
        • Local Institution - 0411
      • Ankara, Turkey, 06200
        • Local Institution - 0375
      • Kayseri, Turkey
        • Local Institution - 0187
      • İzmir, Turkey, 35100
        • Local Institution - 0188
    • İstanbul
      • Stanbul, İstanbul, Turkey, 34214
        • Local Institution - 0325
      • Cardiff, United Kingdom, CF14 4XW
        • Local Institution - 0350
      • Derby, United Kingdom, DE22 3NE
        • Local Institution - 0344
      • Manchester, United Kingdom, M20 4BX
        • Local Institution - 0343
    • Hampshire
      • Southampton, Hampshire, United Kingdom, SO16 0YD
        • Local Institution - 0349
    • London, City Of
      • London, London, City Of, United Kingdom, NW1 2PG
        • Local Institution - 0342
    • Alabama
      • Birmingham, Alabama, United States, 35294
        • Local Institution - 0151
    • California
      • Los Angeles, California, United States, 90095
        • Local Institution - 0088
      • Stanford, California, United States, 94305
        • Local Institution - 0358
    • Connecticut
      • New Haven, Connecticut, United States, 06520
        • Local Institution - 0355
    • District of Columbia
      • Washington, District of Columbia, United States, 20007
        • Local Institution - 0434
    • Kansas
      • Wichita, Kansas, United States, 67214
        • Local Institution - 0433
    • Kentucky
      • Saint Matthews, Kentucky, United States, 40207
        • Local Institution - 0439
    • Louisiana
      • New Orleans, Louisiana, United States, 70112
        • Local Institution - 0323
    • Maryland
      • Baltimore, Maryland, United States, 21218
        • Local Institution - 0324
      • Bethesda, Maryland, United States, 20889
        • Local Institution - 0441
    • Montana
      • Billings, Montana, United States, 59102
        • Local Institution - 0435
    • New Jersey
      • Hackensack, New Jersey, United States, 07601
        • Local Institution - 0157
      • Summit, New Jersey, United States, 07901
        • Local Institution - 0359
    • New York
      • Lake Success, New York, United States, 11042
        • Local Institution - 0430
      • New York, New York, United States, 10065
        • Local Institution - 0396
    • Ohio
      • Cincinnati, Ohio, United States, 45220
        • Local Institution - 0306
      • Cleveland, Ohio, United States, 44109
        • Local Institution - 0199
    • Pennsylvania
      • Pittsburgh, Pennsylvania, United States, 15224
        • Local Institution - 0437
    • Rhode Island
      • Providence, Rhode Island, United States, 02903
        • Local Institution - 0352
    • South Dakota
      • Watertown, South Dakota, United States, 57201
        • Local Institution - 0420
    • Texas
      • Dallas, Texas, United States, 75390-88520
        • Local Institution - 0168
    • Washington
      • Seattle, Washington, United States, 98109
        • Local Institution - 0405

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria

  • Participant is willing and able to adhere to the study visit schedule and other protocol requirements including bone marrow aspirations and/or biopsies and hospitalization during the first cycle.
  • Documented diagnosis of multiple myeloma (MM), and must:.

    i) Received at least 1 but not more than 3 prior lines of anti-myeloma therapy.

ii) Received prior treatment with lenalidomide and an anti-CD38 monoclonal antibody (for at least 2 consecutive cycles).

iii) Achieved minimal response (MR) or better to at least 1 prior anti-myeloma therapy.

iv) Documented PD during or after their last anti-myeloma therapy or failure to achieve response.

  • Must have measurable disease (as determined by central laboratory).
  • Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2 at the time of the screening.

Exclusion Criteria

  • Active, uncontrolled, or suspected infection.
  • Known current, or history of, central nervous system involvement of multiple myeloma.
  • History or presence of clinically relevant CNS pathology.
  • Received prior BCMA-targeted TCE or BCMA-targeted CAR-T therapy.
  • Previously received allogeneic stem cell transplantation at any time or received autologous stem cell transplantation within 3 months of initiating study intervention.
  • Other protocol-defined Inclusion/Exclusion criteria apply.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm A: Alnuctamab
Specified dose on specified days
Other Names:
  • BMS-986349
  • CC-93269
Active Comparator: Arm B: Standard of Care Regimens
Specified dose on specified days
Specified dose on specified days
Other Names:
  • CC-4047
  • BMS-986379
  • POMALYST®
  • IMNOVID®
Specified dose on specified days
Other Names:
  • KYPROLIS®
Specified dose on specified days
Other Names:
  • BMS-901608
  • Empliciti®
Specified dose on specified days
Other Names:
  • DARZALEX
  • DARZALEX®
  • FASPRO®

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Progression-free Survival (PFS)
Time Frame: Up to 5 years
Up to 5 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Time to response (TTR)
Time Frame: Up to 5 years
Up to 5 years
Duration of response (DOR)
Time Frame: Up to 5 years
Up to 5 years
Overall Survival (OS)
Time Frame: Up to 5 years
Up to 5 years
Incidence of serious adverse events (SAEs)
Time Frame: Up to 5 years
Up to 5 years
Overall response (OR)
Time Frame: Up to 5 years
Up to 5 years
Complete response (CR) or better
Time Frame: Up to 5 years
Up to 5 years
Very good partial response (VGPR) or better
Time Frame: Up to 5 years
Up to 5 years
Time to progression (TTP)
Time Frame: Up to 5 years
Up to 5 years
Time to next treatment (TTNT)
Time Frame: Up to 5 years
Up to 5 years
Progression-free survival 2 (PFS2)
Time Frame: Up to 5 years
Up to 5 years
Restricted mean DOR (RMDOR)
Time Frame: Up to 5 years
Up to 5 years
Minimal residual disease (MRD) negativity rate
Time Frame: Up to 5 years
Up to 5 years
Incidence of adverse events (AEs)
Time Frame: Up to 5 years
Up to 5 years
Change from baseline in subscale scores of European organization for research and treatment of cancer - quality of life core 30 (EORTC QLQ-C30)
Time Frame: Up to 5 years
Up to 5 years
Change from baseline in subscale scores of European quality of life multiple myeloma module (EORTC QLQ-MY20)
Time Frame: Up to 5 years
Up to 5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Bristol-Myers Squibb, Bristol-Myers Squibb

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 3, 2024

Primary Completion (Estimated)

November 16, 2025

Study Completion (Estimated)

September 21, 2030

Study Registration Dates

First Submitted

January 22, 2024

First Submitted That Met QC Criteria

January 22, 2024

First Posted (Actual)

January 31, 2024

Study Record Updates

Last Update Posted (Actual)

May 31, 2024

Last Update Submitted That Met QC Criteria

May 30, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria.

Additional information regarding Bristol Myer Squibb's data sharing policy and process can be found at:

https://www.bms.com/researchers-and-partners/clinical-trials-and-research/disclosurecommitment.html

IPD Sharing Time Frame

See Plan Description

IPD Sharing Access Criteria

See Plan Description

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Myeloma

Clinical Trials on Dexamethasone

Subscribe